FIELD: medicine, veterinary medicine, pharmacy and pharmacology.
SUBSTANCE: invention relates to the use of 1-(2-thienyl)-4H-[1,2]oxazino[5,4-b]quinoline-4,10(5H)-dione as a means with radical-binding activity. The invention may find application as an antioxidant for the treatment of humans and animals.
EFFECT: radical-binding activity of 1-(2-thienyl)-4H-[1,2]oxazino[5,4-b]quinoline-4,10(5H)-dione.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RADICAL BINDING AGENT BASED ON ACYLPYRUVIC ACID DERIVATIVES | 2022 |
|
RU2800386C1 |
| 1H-PYRROLO[3,4-b]QUINOLINE-3,9(2H,4H)-DIONES EXHIBITING ANTI-TUBERCULOSIS ACTIVITY AND METHOD FOR PREPARING THEM | 2009 |
|
RU2457208C2 |
| 11b-(HET)ARYL-2,3,611b-TETRAHYDROOXAZOLO[2',3':2,1]PYRROLO[3,4-b]QUINOLIN-5,11-DIONES AND SYNTHESIS METHOD THEREOF | 2007 |
|
RU2381229C2 |
| ANALGESIC MEANS | 2016 |
|
RU2634618C1 |
| INHIBITORS OF AKT ACTIVITY | 2010 |
|
RU2579513C2 |
| METHOD OF ANTIOXIDANT ACTIVITY ASSESSMENT | 2009 |
|
RU2392623C1 |
| CAMPTOTHECIN ANALOGS, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1997 |
|
RU2190613C2 |
| TRICYCLIC DERIVATIVES, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION, AND METHOD OF INHIBITION OF VASOPRESSINE | 1994 |
|
RU2149160C1 |
| METHOD FOR PREPARING 6-ARYL-5-(3-OXO-4-PHENYL-3,4-DIHYDROQUINOXALIN-2-YL)-2,3-DIHYDRO-4H-1,3-OXAZIN-4-ONES | 2021 |
|
RU2763022C1 |
| 4-SUBSTITUTED N-ARYL-1,8-NAPHTHALIMIDES, EXHIBITING PROPERTIES OF FLUORESCENT SENSORS ON METAL CATIONS AND METHODS FOR PRODUCTION THEREOF | 2012 |
|
RU2515195C1 |
